A randomised trial of lung sealant<i>versus</i>medical therapy for advanced emphysema
George R. Washko(Brigham and Women's Hospital), Gerard J. Criner(Temple University Hospital), Samaan Rafeq, Grigoris Stratakos, Mordechai R. Kramer(Rabin Medical Center), Michael Boyd, Thomas R. Gildea, Patrick Whitten, Mark T. Dransfield(University of Alabama at Birmingham), Surya P. Bhatt(University of Alabama at Birmingham), John Walsh, Mark H. Gotfried(Pulmonary Associates), Muhanned Abu‐Hijleh, Dirk‐Jan Slebos(University Medical Center Groningen), Javier Flandes, Javier J. Zulueta(Mount Sinai Hospital), Alexander M. Sy, Alexander C. Chen, Víctor Pinto-Plata(St. Elizabeth's Medical Center), Nathaniel Marchetti, Roger D. Yusen(Washington University in St. Louis), David Berkowitz, Michela Bezzi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Kumaran Kolandaivelu, Timothy Liesching, Christopher B. Cooper(Johns Hopkins University), Larry Tsai, D. Kyle Hogarth(MACOM (United States)), Michael A. Pritchett, Richard A. Mularski, J. Michael Wells(University of Alabama at Birmingham), Enrique Cases, Momen M. Wahidi(Northwestern University), Edmundo Rubio, Charles‐Hugo Marquette(Hôpital Pasteur), William Leeds
Cited by 122
Related Papers
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD
|Journal of Clinical Investigation|2014|620
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
|New England Journal of Medicine|2011|615